BusinessActinium Pharmaceuticals to Present Actimab-A Data at the 10th International Symposium on Targeted Alpha TherapyBy Nasdaq OMXMay 23, 2017, 11:32 AM UTC
BusinessActinium Pharmaceuticals to Present Actimab-A Data at the 10th International Symposium on Targeted Alpha TherapyBy Nasdaq OMXMay 23, 2017, 11:32 AM UTC
BusinessActinium Pharmaceuticals Announces Appointment of Hematology Expert Dr. Richard Stone of the Dana-Farber Cancer Institute to its Scientific Advisory BoardBy Nasdaq OMXMay 17, 2017, 11:01 AM UTC
BusinessActinium Pharmaceuticals Announces Appointment of Hematology Expert Dr. Richard Stone of the Dana-Farber Cancer Institute to its Scientific Advisory BoardBy Nasdaq OMXMay 17, 2017, 11:01 AM UTC
BusinessActinium Pharmaceuticals Receives Clearance from Health Canada to Initiate Pivotal Phase 3 SIERRA Trial of Iomab-BBy Nasdaq OMXMay 10, 2017, 11:01 AM UTC
BusinessActinium Pharmaceuticals Receives Clearance from Health Canada to Initiate Pivotal Phase 3 SIERRA Trial of Iomab-BBy Nasdaq OMXMay 10, 2017, 11:01 AM UTC
BusinessActinium Pharmaceuticals Announces Sponsorship of the Acute Leukemia Forum 2017By Nasdaq OMXApr 18, 2017, 11:00 AM UTC
BusinessGeron Reports Imetelstat Presentation at American Association for Cancer Research Annual MeetingBy Nasdaq OMXApr 5, 2017, 11:30 AM UTC
